Dharma Bioscience
Rosario
About Dharma Bioscience
Dharma Bioscience is at the forefront of developing an innovative injectable treatment utilizing modified microRNAs to promote cartilage regeneration in patients with osteoarthritis. This advanced therapy offers a straightforward administration method for physicians worldwide, reducing the necessity for invasive joint replacement surgeries. By providing a non-invasive alternative, this injectable solution not only minimizes recovery time and associated costs but also presents patients with a safer and more accessible option for managing their condition.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $280.0K
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: dharmabioscience.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/dharma-bioscience-151967 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.